Brady Laughlin MD

Pediatric Radiation Oncology, Urologic Cancer

Radiation Oncologist at Mayo Clinic Arizona

5777 E Mayo BlvdPhoenix, AZ 85054
Phone+1 480-515-6296

Dr. Laughlin is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Laughlin's full profile Already have an account?

Summary

Dr. Brady Laughlin, located in Phoenix, AZ, is a radiation oncologist specializing in pediatric radiation oncology and urologic cancer. A graduate of the University of Arizona College of Medicine in 2019, Dr. Laughlin completed a residency in radiation oncology at Mayo Clinic College of Medicine and Science, Phoenix, from 2019 to 2024, and is currently employed at Mayo Clinic Hospital. Dr. Laughlin has authored multiple publications in reputable journals, addressing topics such as treatment approaches for prostate cancer and innovative methods in radiation oncology. Dr. Laughlin was recognized as a member of the Alpha Omega Alpha Honor Medical Society in 2017.

Education & Training

Mayo Clinic College of Medicine and Science (Phoenix)Residency, Radiation Oncology, 2019 - 2024
University of Arizona College of MedicineClass of 2019

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2024 - 2028
NM State Medical License 2024 - 2028
AZ State Medical License 2020 - 2027
CO State Medical License 2024 - 2027
NV State Medical License 2024 - 2027
OR State Medical License 2024 - 2027
TX State Medical License 2024 - 2026
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Member Alpha Omega Alpha Honor Medical Society, 2017

Publications & Presentations

PubMed

From idealism to disillusionment: professional fulfillment, burnout, and retention across the multidisciplinary radiation oncology workforce.
Brady S Laughlin, Astha Rohit, Sarah James, Steven Schild, Heather Billings
Radiotherapy and Oncology. 2026-08-06
Impact of modern central nervous system radiation on multiple sclerosis relapse and progression.
Hannah H Zhao-Fleming, Daniel K Ebner, William Sperduto, Brady S Laughlin, Daniel H Lachance
Clinical and Translational Radiation Oncology. 2026-07-01
Aligning Medical Education With Modern Cancer Care: The Role of Radiation Oncology.
Brady S Laughlin, Steve Braunstein, Nima Nabavizadeh, Albert Attia, Mona Arbab
Practical Radiation Oncology. 2026-06-28

Journal Articles

Physician and Patient-Reported Outcomes of the MC1635 Phase III Trial of Ultra-Hypofractionated Versus Moderate Hypofractionated Adjuvant Radiotherapy After Breast-Con...
Brady S. Laughlin MD , Kimberly A. Corbin MD , Diego Augusto Santos Toesca MD , Cameron S. Thorpe MD , Michael A. Golafshar MS , Barbara Pockaj MD , Patricia Cronin MD..., International Journal of Radiation Oncology, Biology, Physics, 10/30/2023

Lectures

Clinical outcome associated with neoadjuvant chemoradiation and orthotopic liver transplantation versus definitive chemoradiation in 49 patients with unresectable, hil...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020